Cinvanti and Famotidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cinvanti (aprepitant) and Famotidine (famotidine). Common drug interactions include vomiting among females.

The phase IV clinical study analyzes what interactions people have when they take Cinvanti and Famotidine. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Cinvanti?

Cinvanti has active ingredients of aprepitant. eHealthMe is studying from 150 Cinvanti users. Check the latest studies of Cinvanti.

What is Famotidine?

Famotidine has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 83,421 Famotidine users. Check the latest studies of Famotidine.

On Jul, 16, 2026

14 people who take Cinvanti and Famotidine together, and have interactions are studied.

Cinvanti and Famotidine drug interactions.

What are the common drug interactions of Cinvanti and Famotidine, by gender? *:

female:

Vomiting
Nausea (feeling of having an urge to vomit)
Throat tightness
Diarrhoea
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
Febrile neutropenia (fever with reduced white blood cells)
Neutropenia (an abnormally low number of neutrophils)
Adverse drug reaction
Drug hypersensitivity
Obstruction gastric (obstruction in stomach)

male:

n/a

What are the common drug interactions of Cinvanti and Famotidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Throat irritation
Throat tightness
Vomiting
Nausea (feeling of having an urge to vomit)
Obstruction gastric (obstruction in stomach)

50-59:

Nausea (feeling of having an urge to vomit)
Vomiting

60+:

Diarrhoea
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
Febrile neutropenia (fever with reduced white blood cells)
Neutropenia (an abnormally low number of neutrophils)
Adverse drug reaction

What are the existing conditions these people have? *

Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 14.29%
Multiple Myeloma (cancer of the plasma cells): 2 people, 14.29%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 2 people, 14.29%
Hypokalemia (low potassium): 2 people, 14.29%
Febrile Neutropenia (fever with reduced white blood cells): 2 people, 14.29%
Endometrial Cancer: 2 people, 14.29%
Dehydration (dryness resulting from the removal of water): 2 people, 14.29%
Breast Cancer Metastatic: 2 people, 14.29%
Blood Creatinine Increased: 2 people, 14.29%
Asthma: 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Cinvanti and Famotidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously